Recipharm Delivers Serialization Solutions for Abbott in Korea
PTSM: Pharmaceutical Technology Sourcing and Management
Recipharm expects to be rolling out further serialization projects during 2015.
CDMO, Recipharm has completed a serialization project in Korea for its customer, Abbott. The project started in April 2014.
According to Recipharm, its serialization solutions meet customer and market requirements, such as the production of data matrix codes and serial numbers. The CDMO’s applied its internationally adaptable solution to ensure full compliance with complex registrations and serialization regulations in Korea.
The manufacture of validation batches has begun, with release and shipping to Korea expected in mid-March 2015. Recipharm stated in a press release that cost was kept to a minimum for this serialization project and full implementation was achieved. Recipharm is expecting to roll out further projects during the year.
Source: Recipharm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
